Compare Enveric Biosciences Inc (ENVB) vs YieldMax AI & Tech Portfolio Option Income ETF (GPTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs YieldMax AI & Tech Portfolio Option Income ETF — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while YieldMax AI & Tech Portfolio Option Income ETF trades at $42.75. The key difference: YieldMax AI & Tech Portfolio Option Income ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | GPTY | |
|---|---|---|
Market Cap | $6.20M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $17.40 | $50.52 |
52-Week Low | $1.27 | $34.73 |
Enterprise Value | $1.30M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.55, down 0.64% with a bullish technical signal despite negative profitability. The company shows promising clinical progress with its lead candidate EB-003, supported by recent FDA guidance and positive preclinical data. While quarterly earnings consistently beat expectations, the company remains unprofitable with negative ROE and ROA. Analyst sentiment is positive with 75% buy ratings.
Investment outlook hinges on successful drug development milestones, with regulatory progress and intellectual property expansion providing catalysts. Key risks include clinical trial outcomes, cash burn from operations, and dependence on financing activities. The stock presents speculative growth potential for risk-tolerant investors focused on biotech innovation.
GPTY trades at $42.64, up 0.94% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF focuses on AI and tech equities, using options strategies to generate weekly dividends, with recent payouts ranging from $0.28 to $0.37. Support and resistance levels are clustered around $41-$43, indicating tight trading ranges.
Outlook is supported by AI theme momentum and income generation, but risks include semiconductor concentration and NAV erosion from options strategies. Investor sentiment is mixed, with some analysts highlighting yield sustainability concerns versus exposure benefits.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About YieldMax AI & Tech Portfolio Option Income ETF
GPTY is an actively managed ETF that seeks to provide current income and capital appreciation by holding a concentrated portfolio of 15 to 30 leading AI and technology companies. It utilizes a variety of options strategies, including selling call options on its underlying holdings, to generate weekly distributions while maintaining direct equity exposure to the growth of the AI sector.
Read more on GPTY →
